Abstract |
Naphazoline, a nonspecific alpha- adrenoceptor stimulant, is a potent vasoconstrictor used in nasal sprays, eye drops, and over-the-counter antiseptics. Naphazoline intoxication increases afterload by constricting the peripheral arteries, which can lead to complications including multiple organ failure. Although phentolamine, a nonselective alpha- adrenoceptor antagonist, and nicardipine, a calcium channel blocker, are used for the treatment of naphazoline intoxication, no established administration protocols currently exist. We present the case of a 32-year-old male with depression who ingested 150 mL of an antiseptic containing 0.1% naphazoline (equivalent to 150 mg of naphazoline). Five hours after ingestion, the patient was admitted to hospital exhibiting signs of naphazoline intoxication, such as bradycardia (46 beats/min), blood pressure of 166/122 mmHg, and peripheral cyanosis. We used the FloTrac™/EV1000™ system (Edwards Lifesciences, Irvine, CA, USA), a minimally invasive cardiac output monitoring system, to monitor systemic vascular resistance. The systemic vascular resistance index (SVRI) was elevated (4457 dyne.s/cm5/m2; nomal range: 1970-2390 dyne.s/cm5/m2) upon admission and initial treatment with continuous intravenous infusion of phentolamine led to SVRI normalization within 2 h. With the goal of maintaining SVRI normalization, continuous infusion with nicardipine was then started. At 10 h after treatment initiation, the nicardipine dose peaked at 9 mg/h (1.9 μg/kg/min). Treatment was discontinued 8 h later, and the patient was discharged on the fourth day without sequelae. In conclusion, the use of a minimally invasive cardiac output monitoring system to track vascular resistance can effectively guide the dosing of phentolamine or nicardipine in the treatment of naphazoline intoxication.
|
Authors | Takatoshi Oishi, Masahiro Kashiura, Hideto Yasuda, Yuki Kishihara, Keiichiro Tominaga, Hiroyuki Tamura, Takashi Moriya |
Journal | The American journal of emergency medicine
(Am J Emerg Med)
Vol. 77
Pg. 233.e5-233.e7
(Mar 2024)
ISSN: 1532-8171 [Electronic] United States |
PMID | 38155033
(Publication Type: Case Reports)
|
Copyright | Copyright © 2023 Elsevier Inc. All rights reserved. |
Chemical References |
- Naphazoline
- Phentolamine
- Nicardipine
- Receptors, Adrenergic
|
Topics |
- Male
- Humans
- Adult
- Naphazoline
- Phentolamine
- Nicardipine
- Cardiac Output
- Receptors, Adrenergic
|